News Conference News EHRA 2019 Coping With CABANA: Despite Trial Flaws, A-fib Experts Say Lessons Have Been Learned Todd Neale March 26, 2019
News Conference News ACC 2019 First Ticagrelor Reversal Agent Shows Quick Onset, Long Duration in Early Results Yael L. Maxwell March 25, 2019
News Conference News ACC 2019 Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD Shelley Wood March 22, 2019
News Conference News ACC 2019 REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events Yael L. Maxwell March 22, 2019
News Conference News ACC 2019 TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients Yael L. Maxwell March 17, 2019
News Conference News ACC 2019 Spectrum of Shock Treated in Contemporary US Practice: Clues From the CCCTN Caitlin E. Cox March 16, 2019
News Conference News ACC 2019 Apple Watch May Detect A-fib in the General Population, but at What Cost? Yael L. Maxwell March 16, 2019
News Conference News ACC 2019 Under 40, or 10 Years Older: MI Survivors Face Similar Long-term Mortality Risks Todd Neale March 07, 2019
News Conference News ISC 2019 Getting Women More Involved at the International Stroke Conference: Theories, Data, and Solutions Todd Neale February 12, 2019
News Conference News STS 2019 TAVR Outcomes Dependent on SAVR Hospital Volumes Yael L. Maxwell January 28, 2019
News Conference News ISET 2019 PAD in the Spotlight: Awareness, Treatment Remain Low Despite Many Years of Research Caitlin E. Cox January 28, 2019
News Conference News WCC 2018 CVD, Other Noncommunicable Diseases Hit Lower-Income Countries With Heavy Financial Burden Todd Neale December 06, 2018
News Conference News WCC 2018 WHF Celebrates 40th Anniversary as World Congress Kicks Off in Dubai Todd Neale December 05, 2018
News Conference News AHA 2018 Greater Need for Cooperative Care in Women’s Heart Health, Two Studies Suggest Yael L. Maxwell November 16, 2018
News Conference News AHA 2018 EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits Michael O'Riordan November 16, 2018
News Conference News AHA 2018 Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study Michael O'Riordan November 15, 2018
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Conference News AHA 2018 Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI Michael O'Riordan November 14, 2018
News Conference News AHA 2018 Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis Caitlin E. Cox November 13, 2018